Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.001 Per Share
-
Shares outstanding
-
47M
-
Number of holders
-
248
-
Total shares
-
46.6M
-
Shares change
-
+289K
-
Total reported value, excl. options
-
$1.87B
-
Value change
-
+$9.97M
-
Put/Call ratio
-
0.67
-
Number of buys
-
126
-
Number of sells
-
-134
-
Price
-
$40.07
Significant Holders of Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) as of Q2 2023
252 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share as of Q2 2023.
Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) has 248 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.6M shares
of 47M outstanding shares and own 99.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.48M shares), VANGUARD GROUP INC (4.95M shares), STATE STREET CORP (1.72M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.69M shares), BAILLIE GIFFORD & CO (1.66M shares), RENAISSANCE TECHNOLOGIES LLC (1.57M shares), Invesco Ltd. (1.38M shares), Stephens Investment Management Group LLC (1.34M shares), Clearbridge Investments, LLC (1.15M shares), and DIMENSIONAL FUND ADVISORS LP (1.12M shares).
This table shows the top 248 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.